4//SEC Filing
Halfon Jean Michel 4
Accession 0001209191-18-049515
CIK 0000818686other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:08 PM ET
Size
7.4 KB
Accession
0001209191-18-049515
Insider Transaction Report
Form 4
Halfon Jean Michel
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2018-09-03+2,162→ 2,162 total - Exercise/Conversion
Restricted Share Units
2018-09-03−2,162→ 0 total→ Ordinary Shares (2,162 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on October 7, 2015 and vested on September 3, 2018.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001721516
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:08 PM ET
- Size
- 7.4 KB